Contact

The future of therapeutics is now

We revolutionize the journey from molecular design to clinical manufacturing, with a vertically integrated business model offering everything you need under one roof.

Explore our Rare Disease Tissue Registry

What sets us apart

A Vertically Integrated Platform

We combine protein engineering, disease modeling, therapeutic development, and manufacturing in a single organization.

Modeling + Therapeutics

We develop patient-derived iPSC and mesenchymal stem cell disease models alongside therapeutic programs, creating a “human mirror” to test therapies before clinical development.

Multi-Modal Expertise

We work across monoclonal antibodies, bispecifics, trispecifics, ADCs, nanobodies, fusion proteins, cell therapies, growth factors, and regenerative medicine applications.

Under One Roof

With our own laboratory, pilot manufacturing, purification, and process development capabilities, we handle it all.

Pipeline

Our portfolio spans antibody-drug conjugates, intranasal BDNF, cell therapies, and more.

Our Signature Therapeutics

From rare disease and neuroscience to oncology and wound healing, our biologics open the door to exciting possibilities.

Our Story

Founded in 2024, ORF Bio combines drug development, disease modeling, and biologics manufacturing in a single integrated platform.

More than 300 million people around the world live with a rare disease.

Our rare disease tissue registry is advancing the understanding and treatment of rare diseases.

Explore the registry Information for patients

Latest News & Events

View all news